Page last updated: 2024-08-25

rosiglitazone and 16,16-dimethylprostaglandin e2

rosiglitazone has been researched along with 16,16-dimethylprostaglandin e2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Farokhzad, OC; Langer, R; Xu, X; Xue, Y; Zhang, XQ	1

Other Studies

1 other study(ies) available for rosiglitazone and 16,16-dimethylprostaglandin e2

Article	Year
Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles. Proceedings of the National Academy of Sciences of the United States of America, 2016, May-17, Volume: 113, Issue:20 Topics: 16,16-Dimethylprostaglandin E2; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Carbohydrate Metabolism; Diet; Drug Delivery Systems; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Nanomedicine; Nanoparticles; Neovascularization, Physiologic; Obesity; Rosiglitazone; Thiazolidinediones	2016

Article

Year

Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles.

Proceedings of the National Academy of Sciences of the United States of America, 2016, May-17, Volume: 113, Issue:20

Topics: 16,16-Dimethylprostaglandin E2; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Carbohydrate Metabolism; Diet; Drug Delivery Systems; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Nanomedicine; Nanoparticles; Neovascularization, Physiologic; Obesity; Rosiglitazone; Thiazolidinediones

2016